Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
LivaNova PLC - Ordinary Shares
(NQ:
LIVN
)
69.87
-0.42 (-0.60%)
Streaming Delayed Price
Updated: 10:15 AM EST, Feb 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about LivaNova PLC - Ordinary Shares
< Previous
1
2
3
4
5
6
Next >
LivaNova (LIVN) Q4 2025 Earnings Call Transcript
↗
February 25, 2026
LivaNova (LIVN) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
World Trade
LivaNova (NASDAQ:LIVN) Beats Q4 Estimates, Provides Steady 2026 Outlook
↗
February 25, 2026
Via
Chartmill
LivaNova Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Guidance
February 25, 2026
From
LivaNova PLC
Via
Business Wire
LivaNova to Announce Fourth-Quarter and Full-Year 2025 Results
January 20, 2026
From
LivaNova PLC
Via
Business Wire
Earnings Scheduled For November 5, 2025
↗
November 05, 2025
Via
Benzinga
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
LivaNova to Present at J.P. Morgan Healthcare Conference in January
December 23, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Highlight Real-World Evidence from CORE-VNS Study and New Health Economics Analyses at American Epilepsy Society 2025 Annual Meeting
December 03, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea
December 02, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Present at Piper Sandler Healthcare Conference in December
November 25, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova’s VNS Therapy for Drug-Resistant Epilepsy Procedures Receives Increased Provider Reimbursement from U.S. Centers for Medicare & Medicaid Services
November 24, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova Delivers Strategic Roadmap and Long-Range Financial Plan at Investor Day
November 12, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova PLC (NASDAQ:LIVN) Beats Q3 2025 Estimates and Raises Full-Year Guidance
↗
November 05, 2025
LivaNova (LIVN) beat Q3 2025 earnings and revenue estimates, raising its full-year guidance on strong performance across its Cardiopulmonary and Neuromodulation segments.
Via
Chartmill
LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance
November 05, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Present at Wolfe Research Healthcare Conference in November
October 23, 2025
From
LivaNova PLC
Via
Business Wire
Inspire Medical Systems Soars 3.9% on Groundbreaking Inspire V Clinical Data
October 13, 2025
Minneapolis, MN – October 13, 2025 – Inspire Medical Systems (NYSE: INSP) emerged as a standout performer in today's trading session, witnessing its stock price jump by an impressive 3.9% by the...
Via
MarketMinute
LivaNova to Announce Third-Quarter 2025 Results
October 08, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Present Scientific Data at International Surgical Sleep Society 2025 Annual Meeting
October 07, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova Appoints Donald Zurbay as a New Director
September 04, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Host Investor Day on November 12, 2025
August 25, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Present at Baird and Morgan Stanley Global Healthcare Conferences in September
August 22, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova Launches Essenz Perfusion System in China
August 18, 2025
From
LivaNova PLC
Via
Business Wire
Shopify, Astera Labs, Myriad Genetics, Grocery Outlet And Other Big Stocks Moving Higher On Wednesday
↗
August 06, 2025
Via
Benzinga
LivaNova Reports Second-Quarter 2025 Results; Raises 2025 Guidance
August 06, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Announce Second-Quarter 2025 Results
July 09, 2025
From
LivaNova PLC
Via
Business Wire
CORE-VNS Study Further Validates Effectiveness of LivaNova’s VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy
June 05, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy
June 05, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression
June 04, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova to Present at the Jefferies Global Healthcare Conference
May 15, 2025
From
LivaNova PLC
Via
Business Wire
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance
May 07, 2025
From
LivaNova PLC
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
